glp 1 and gip glp 1 receptor agonists New Weight-Loss Drugs Are Poised to Upend Preventive Cardiology Care in Patients With Obesity Overweight Dual and Triple Gut Peptide
Description
A complete list of search strategies can be found in appendix 1
Rona emphasizes that "water with or without natural flavors and electrolyte-based fluids are the preferred sources of hydration
This class of drugs is challenging outdated beliefs that obesity is an issue of individual behavior and willpower
The cost of the medication is an added fee
Additionally, the FDA said in July that it had received reports of overdoses related to weight loss drugs, often due to confusion over proper dosing
February 9, 2026
